Product NDC: | 49349-560 |
Proprietary Name: | PYRIDOSTIGMINE BROMIDE |
Non Proprietary Name: | PYRIDOSTIGMINE BROMIDE |
Active Ingredient(s): | 60 mg/1 & nbsp; PYRIDOSTIGMINE BROMIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49349-560 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040502 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130403 |
Package NDC: | 49349-560-20 |
Package Description: | 100 TABLET in 1 CANISTER (49349-560-20) |
NDC Code | 49349-560-20 |
Proprietary Name | PYRIDOSTIGMINE BROMIDE |
Package Description | 100 TABLET in 1 CANISTER (49349-560-20) |
Product NDC | 49349-560 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | PYRIDOSTIGMINE BROMIDE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130403 |
Marketing Category Name | ANDA |
Labeler Name | REMEDYREPACK INC. |
Substance Name | PYRIDOSTIGMINE BROMIDE |
Strength Number | 60 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |